Safety comparison of additives in antiglaucoma prostaglandin (PG) analog ophthalmic formulations

PURPOSE: To investigate the safety of five types of antiglaucoma prostaglandin analog ophthalmic formulations, and to clarify their differences in accordance with contained additives (preservatives and surface-active agents). METHODS: The following five types of ophthalmic solutions and three types...

Descripción completa

Detalles Bibliográficos
Autores principales: Fukuda, Masamichi, Shibata, Shinsuke, Shibata, Naoko, Hagihara, Kenta, Yaguchi, Hiromoto, Osada, Hiromi, Takahashi, Nobuo, Kubo, Eri, Sasaki, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601024/
https://www.ncbi.nlm.nih.gov/pubmed/23515900
http://dx.doi.org/10.2147/OPTH.S40147

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601024/
https://www.ncbi.nlm.nih.gov/pubmed/23515900
http://dx.doi.org/10.2147/OPTH.S40147

Ejemplares similares